Long-term effects of cyclosporine A in Alport's syndrome.
tive, and thickening of the glomerular basement memwere published. A significant decrease in or disappearance brane by electron microscopy with splitting and splinterof proteinuria and apparently good tolerance to CsA were ing of the lamina densa [2] [3] [4] [5] [6] [7] [8] [9] [10] . In our experience and observed in all patients.
Methods. CsA administration has been maintained in these that of other authors, the presence of massive proteinuria eight patients with the aim of obtaining further information is suggestive of a poor prognosis toward eventual renal about the clinical course of the disease. The ages of these eight failure [1, 5, 7, [9] [10] [11] [12] .
patients currently range from 15 to 27 years, and the mean Eight patients described in our previous report [1] met duration of treatment is from 7 to 10 years (x ϭ 8.4 years).
these criteria and were selected to receive CsA treatment
Results. Renal function has remained stable, with no evaluable changes in serum creatinine levels compared with pre-(after parental consent had been obtained) because of ties was verified in three generations of each family.
Conclusions. After a mean duration of 8.4 years and with
The clinical features of these eight patients (mean age no deterioration in renal function, we found possible beneficial of 12.2 Ϯ 4.27 years) at the beginning of the study are effects of the continued treatment of CsA in patients with shown in Table 1 . Arterial blood pressure was normal Alport's syndrome who present evidence of progression to renal insufficiency. in all patients except one, who required antihypertensive therapy; seven patients had nerve deafness, and ocular abnormalities were present in two. Creatinine clearance In 1991, we published a study of the effects of cyclowas normal in five patients and was moderately low in sporine A (CsA) on proteinuria in eight patients with the other three; maximum urinary osmolarity was normal Alport's syndrome who presented with significant renal in six patients (1025.8 Ϯ 110.4 mOsm/kg) and decreased involvement [1] . CsA was observed to have a marked in two patients with low creatinine clearance (patients and sudden early reducing effect on proteinuria in all of 7 and 8; Table 1 ). Proteinuria was persistent and massive them. Owing to the good patient tolerance to CsA and in all of them, ranging from 46 to 207 mg/hr/m 2 . its persistence of action on proteinuria, administration Since the publication of our first article in 1991 [1], has been continued up to the present for the purpose of CsA administration has been continued in these eight obtaining more information about the potentially posipatients. The initial total daily dose of CsA was 5 mg/ tive effects on the clinical course of the disease.
kg/day (half of the dose being given every 12 hr), in the search for the optimum dose required to maintain mean levels of 82 Ϯ 13 ng/ml. The present age of these patients METHODS ranges between 15 and 27 years, with a mean of 20.1 The diagnosis of Alport's syndrome was based on the years, and the duration of CsA treatment currently ranges presence of hematuric nephropathy, a family history of from 7 to 10 years. During these years of CsA treatment, proteinuria, creatinine clearance, maximum urinary os-Proteinuria was measured by using a 24-hour urine collection by sulfosalicylic acid precipitation and turbi- dimetry. Creatinine clearance was calculated from the has appeared in case 3. Endogenous creatinine clearance is normal in five patients (cases 1, 2, 3, 4, and 6) and has serum creatinine concentration and rates of creatinine excretion over a 24-hour period. Maximum urinary osnot varied noticeably in the remaining three cases (cases 5, 7, and 8) who had been in renal insufficiency prior to molarity was measured after a 10-hour nocturnal hydropenic period, and urine was investigated for a cryothe start of the study ( Fig. 2 and Table 1 ). In all of these, macroscopic hematuria has persisted. Proteinuria has scopic decrease. CsA was measured in total blood by specific monoclonal radioimmunoassay. Liver function ranged from negative (cases 1 and 2) to 20.4 to 50.6 mg/ hr/m 2 in the six remaining cases ( Fig. 3 and Table 1 ). was regularly evaluated.
Two renal biopsies were performed in these eight paThe maximum urinary osmolarity was maintained between 898 and 991 mOsm/kg in cases 1, 2, 3, and 4 and tients: the first before CsA administration and the second in all patients after four to five years of CsA treatment.
was decreased in the other four cases to 782, 824, 560, and 410 mOsm/kg, respectively (Table 1) . Hematoxylin-eosin, periodic acid-Schiff stain, Massontrichrome, and silver-methenamine were performed on
The second biopsy, performed after four to five years of CsA administration, revealed no worsening of the representative sections. Immunofluorescence stains and electron microscopy were also performed.
initial lesion, and vascular lesions suggestive that cyclosporine intoxication, such as arteriolar hyalinosis, were not observed. Thus, in cases with minimal mesangial RESULTS proliferation, this continues to be the same, and focal The first renal biopsy performed before the start of segmental sclerotic lesions are neither more diffuse nor CsA administration showed the following features: modmore generalized in the affected cases. No variations erate or light focal and segmental glomerular hypercelluhave appeared on immunofluorescence study. Electron larity on light microscopy in six patients; the remaining microscopy showed irregular thickening and discontinutwo (patients 7 and 8; Table 1 ) had focal and segmental ity of the glomerular basement membrane, and splitting lesions of the tuft due to marked thickening of the gloand splintering of the lamina densa of the glomerular merular basement membrane and mesangial matrix assobasement membrane with the same intensity as observed ciated with hyaline deposits and collagen of capillary in the first biopsy (Fig. 1) . loops. Immunofluorescence was negative in all patients. Electron microscopy showed irregular thickening and DISCUSSION discontinuity of the glomerular basement membrane, as well as the splitting and splintering of the lamina densa Our eight patients with Alport's syndrome fulfill the criteria proposed in the literature as suggestive of rapid of the glomerular basement membrane in all patients.
After 7 to 10 years of continued CsA treatment, the and precocious progression to end-stage renal disease: gross hematuria, massive and persistent proteinuria, senclinico-analytical situation of these eight patients is as follows: A good general status exists. Arterial blood pressorineural deafness with or without anterior lenticonus, as well as diffuse thickening and multilamellation of the sure is normal in seven patients, and the remaining patient (case 8) continues to require two hypotensors for glomerular basement membrane [4, 7, 9, 10, 13, 14]. The effect of CsA on proteinuria in these patients described control. Hypoacusia remains stable in three (cases 1, 2, and 6), has worsened in four (cases 4, 5, 7, and 8), and in our previous report [1] still persists after a 7-to 10- year treatment period (proteinuria remains negative in the glomerular filtration rate in Alport's syndrome ( Fig.  2 and Table 1) [3, 4, 7, 9]. End-stage renal disease develtwo patients and is markedly reduced in the rest). Hypoacusia currently present in all patients has either reops in virtually all affected males with X-linked Alport's syndrome, and several authors have observed that the mained stable or has worsened in three patients. Macroscopic hematuria persists in all of them (Table 1 ). Blood rate of progression to renal failure is fairly constant among affected males within a particular family [7, 9, pressure remains the same, and maximum urinary osmolarity has not changed, except in patients 5 and 6, who [15] [16] [17] . Taking this into account and with all due reserve, it was also interesting to compare the creatinine clearpresented maximum urinary osmolarity of 980 and 920 mOsm/kg prior to CsA and 782 and 804/kg after CsA, ance values of our eight patients with those of other members of their respective families who had presented respectively. Endogenous creatinine clearance is stable in all; it is of interest to note the findings in cases 5, 7, with renal insufficiency (Fig. 4 and Table 2 ). We were able to verify a marked difference with respect to the and 8 in which decreased clearance values were observed at the start of the study and have remained stable since chronological time of onset of the renal insufficiency in favor of patients receiving CsA treatment. CsA levels CsA treatment was started 7 to 10 years earlier, contrary to what is normally observed in the natural evolution of throughout the study were 82 Ϯ 13 ng/ml. There were no signs of hypertrichosis or gingival hypertrophy or by which CsA acts on proteinuria in these patients are not clearly defined, although three basic types may be other more serious side-effects (such as opportunistic infections, malignancies, and so forth). The other eleaccepted: (a) renal vasoconstriction (renal hemodynamic changes); (b) direct action on the permselectivity of the ment to be assessed in these eight patients was the lack of evolution of the histologic lesion or lesions related to glomerular basement membranes, particularly on the electrochemical barrier that repels anionic albumin molCsA effects. There was no aggravation of the existent glomerular lesion or an increase in interstitial fibrosis.
ecules; and (c) the immunological nature that involves lymphokine secretion inhibition [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] . All of these The lesion of the glomerular basement membrane persists in all cases, with the same characteristics in each different actions would slow down disease progression with no variation in the basic type IV collagen lesion. [14, 18, 19] .
Angiotensin-converting enzyme inhibitors do not reKashtan recently affirmed that a demonstrably effective method of slowing down the progression of Alport's duce proteinuria in patients with Alport's syndrome as CsA proved to do in our study [1, [20] [21] [22] . Mechanisms nephropathy does not exist [13] . However, because mes- in patients with Alport's syndrome in whom elements
